Terpenoid content of Valeriana wallichii extracts and antidepressant-like response profiles

Phytotherapy Research

Volumn 24, Issue 5, 2010, Pages 686-691

  Subhan, Fazal ^a   Karim, Nasiara ^a   Gilani, Anwarul Hassan ^b   Sewell, Robert D E ^c  

^a UNIVERSITY OF PESHAWAR   (Pakistan)

^b AGA KHAN UNIVERSITY   (Pakistan)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antidepressant; Aqueous alcoholic extracts; Fluoxetine; Rhizome; Terpenoids; Valeriana wallichi

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PLANT EXTRACT; TERPENOID; UNCLASSIFIED DRUG; VALERIANA WALLICHI EXTRACT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL TEST; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PHYTOCHEMISTRY; RAT; TAIL SUSPENSION TEST; VALERIANA WALLICHI;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; FEMALE; FLUOXETINE; HINDLIMB SUSPENSION; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RHIZOME; TERPENES; VALERIAN;

VALERIANA; VALERIANA WALLICHII; VALERIANACEAE;

EID: 77952064585     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2980     Document Type: Article

References (33)

1. Baquar SR. 1989. Medicinal and poisonous plants of Pakistan. Printas: Karachi; 479-480.
2. Bhattacharyya D, Jana U, Debnath PK, Sur TK. 2007. Initial exploratory observational pharmacology of Valeriana wallichii on stress management: a clinical report. Nepal Medical College Journal 9: 36-39.
3. Bos R, Hendriks H, Scheffer JJC, Woerdenbag HJ. 1998. Cytotoxic potential of valeriana constituents, and valerian tinctures. Phytomedicine 5: 219-225. (Pubitemid 128554051)
4. Bos R, Woerdenbag HJ, Hendriks H, Smit HF, Wikström HV, Scheffer JJC. 1997. Composition of the essential oil from roots and rhizomes of Valeriana wallichii DC. Flavour Fragrance J 12: 123-131. (Pubitemid 27223224)
5. Cavadas C, Araújo I, Cotrim MD, Amaral T, Cunha AP, Macedo T, Ribeiro CF. 1995. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. Arzneimittelforschung 45: 753-755.
6. Chatterjee SS, Bhattacharya SK, Wonnermann M, Singer A, Mller WE. 1998. Hyperforin as a possible antidepressant component of hypericum. Life Sci 63: 499-510. (Pubitemid 28367402)
7. Detke MJ, Rickels M, Lucki I. 1995. Active behavior in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacol 121: 66-72.
8. + channel activation. J Ethnopharmacol 14: 347-352.
9. Karim N. 2007. Pharmacological investigation of the indigenous plant, Valeriana wallichii for depression in animal models. MPhil thesis, University of Peshawar, Pakistan.
10. Keith SJ, Matthews SM. 1993. The value of psychiatric treatment: its efficacy in severe mental disorders. Psychopharmacol Bull 29: 427-430. (Pubitemid 24206387)
11. Keochanthala-Bounthanh C, Beck JP, Haag-Berrurier M, Anton R. 1993. Effects of two monoterpene esters, valtrate and didrovaltrate, isolated from Valeriana wallichii, on the ultra-structure of hepatoma cells in culture. Phytother Res 7: 124-127. (Pubitemid 23106463)
12. Kubacka M, Librowska T, Czarnecki R, Frackowiak B, Lochyhski S. 2006. Anticonvulsant and antidepressant activity of the selected terpene GABA derivatives in experimental tests in mice. Pharmacol Reports 58: 936-943. (Pubitemid 46117747)
13. Malick JB. 1983. Potentiation of yohimbine-induced lethality in mice: predictor of antidepressant potential. Drug Devel Res 3: 357-363.
14. Marder M, Viola H, Wasowski C, Fernandez S, Medina JH, Paladini AC. 2003. 6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacol Biochem Behav 75: 537-545. (Pubitemid 36936888)
15. Mathela CS, Chanotiya CS, Sammal S S, Pant AK, Pandey S. 2005. Compositional diversity of terpenoids in the himalayan Valeriana genera. Chem Biodivers 2: 1174-1182. (Pubitemid 41404117)
16. Mennini T, Gobbi M. 2004. The antidepressant mechanism of Hypericum perforatum. Life Sci 75: 1021-1027.
17. Moller H, Volz H. 1996. Drug treatment of depression in the 1990s. Drugs 52: 625-638.
18. Nadkarni KM. 1976. Indian Medica, 3rd ed. Popular Prakashan: Bombay; 1260-1262.
19. Panijel M. 1985. Treatment of moderately severe anxiety states. Therapiewoche 35: 4659-4668. (Pubitemid 16221591)
20. Porsolt RD. 2000. Animal models of depression: utility for transgenic research. Neurosci Rev 11: 53-58. (Pubitemid 30006576)
21. Porsolt RD, Anton G, Deniel M, Jalfre M. 1978. Behavioral despair in rats: a new animal model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379-391.
22. Porsolt RD, Bertin A, Jalfre M. 1977. Behavioral despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229: 327-336. (Pubitemid 8225714)
23. Quinton RM. 1963. The increase in toxicity of yohimbine induced by imipramine and other drugs in mice. Brit J Pharmacol 21: 51-66.
24. Reynolds EH. 2003. Brain and mind: a challenge for WHO. Lancet 361: 1924-1925.
25. Ron BH, Willis CV, Bone K, Morgan M. 2000. Herbal products: active constituents, mode of action and quality control. Nutrition Res Rev 13: 47-77. (Pubitemid 30495754)
26. Rudolph U, Crestani F, Benke D, Brünig I, Benson JA, Fritschy J-M, Martin JR, Bluethmann H, Möhler H. 1999. Benzodiazepine actions mediated by specific γ-aminobutyric acid receptor subtypes. Nature 401: 796-800. (Pubitemid 129515840)
27. Sofowora EA. 1993. Phytochemical assays. In Medicinal plants and traditional medicine in Africa. 3rd ed. Spectrum Books Ltd: Nigeria; 150-153.
28. Steru L, Chermat R, Thierry B, Simon P. 1985. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacol 85: 367-370. (Pubitemid 15123115)
29. Subhan F, Khan N, Sewell, RDE. 2009. Adulterant profile of illicit street heroin and reduction of its precipitated physical dependence withdrawal syndrome by extracts of St John's wort (Hypericum perforatum). Phytother Res 23: 564-571.
30. Thierry B, Steru L, Simon P, Porsolt RD. 1986. The tail suspension test: ethical considerations. Psychopharmacology 90: 284-285.
31. Vohora SB, Dandiya PC. 1992. Herbal analgesic drugs. Fitoterapia 63: 195-207.
32. Wasowski C, Marder M, Viola H, Medina JH, Paladini AC. 2002 Isolation and identification of 6-methylarpigenin, a competitive ligand for the brain GABA(A) receptors from Valeriana wallichii. Planta Med 68: 934-946. (Pubitemid 35239288)
33. Willner P. 1984. The validity of animal models of depression. Psychopharmacology 83: 1-16.